A gap the current literature has not adequately addressed is the efficacy of parallel targeting of the p38 MAPK and JNK signaling pathways in NSCLC using MAPKCI combinations, which should be investigated in future research. This evidence concerns the gene MAPK8 and non-small cell lung carcinoma.